ralphmossblog.com
Ralph W. Moss, Ph.D., Cancer AdvisorAbout Dr. Moss. Monday, January 30, 2012. FDA Approves First Drug for Advanced BCC Skin Cancer. Jan 30- The Food and Drug Administration (FDA) today approved a drug for the treatment of advanced basal cell carcinoma (BCC). This is the first drug ever approved for this condition and so I think this is important news. The name of the drug is vismodegib (trade name Erivedge. In a clinical trial at the Karamanos Cancer Center, Detroit, published last year, it shrank these advanced skin tumors. This study sho...
http://www.ralphmossblog.com/